VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,204 | -91.1% | 17,674 | -92.7% | 0.00% | – |
| Q4 2022 | $24,865 | -34.6% | 241,407 | -2.5% | 0.00% | – |
| Q3 2022 | $38,000 | -97.1% | 247,498 | -83.5% | 0.00% | – |
| Q2 2022 | $1,320,000 | -3.6% | 1,500,083 | +35.9% | 0.00% | – |
| Q1 2022 | $1,370,000 | +207.2% | 1,104,115 | +382.8% | 0.00% | – |
| Q4 2021 | $446,000 | -32.1% | 228,694 | -4.6% | 0.00% | – |
| Q3 2021 | $657,000 | +1628.9% | 239,730 | +1905.3% | 0.00% | – |
| Q2 2021 | $38,000 | -83.5% | 11,955 | -89.0% | 0.00% | – |
| Q1 2021 | $230,000 | +995.2% | 108,200 | +612.5% | 0.00% | – |
| Q2 2018 | $21,000 | 0.0% | 15,187 | +13.4% | 0.00% | – |
| Q3 2017 | $21,000 | – | 13,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |